Ajanta Pharma Limited

Web: ajantapharma.com NSE: AJANTPHARM BSE: 532331 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

3473 48(-1%)

Near 52W High of 3796

Volume

43k as on 03, Sep

Open

2,662

High

3,030

Low

2,892

3,521

VWAP

3,505

52 Week High

3,796

52 Week Low

2,330

Viand Research Rating

Quality Score

54/100

Growth Score

42/100

Valuation Score

50/100

Momentum Score

50/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

43,400

No. of Shares

12.5

P/E

42.84

P/B

10.36

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

24.19

ROCE

Profit Growth

Listing Date

29-May-00

Promoter Holding

66.25%

FII Holding

8.26%

DII Holding

18.36%

Price Chart

Price Performance

1 Week1%

1 Month0%

3 Months20%

6 Months19%

1 Year35%

YTD20%

Moving Average

5 Day SMA3,533

10 Day SMA3,554

20 Day SMA3,582

30 Day SMA3,533

50 Day SMA3,474

61 Day SMA3,411

80 Day SMA3,329

200 Day SMA3,009

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	3,661	3,514	3,603	3,641
Resistance 2	3,603	3,504	3,557	3,593
Resistance 1	3,542	3,493	3,529	3,522
Pivot Point	3,484	3,482	3,484	3,474
Support 1	3,423	3,471	3,438	3,403
Support 2	3,365	3,460	3,410	3,355
Support 3	3,304	3,449	3,365	3,284

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,56,655	1899	0%	2%	9%	21%	37	57.7	0.07	11509
2	DIVISLAB	2,43,196	9161	2%	8%	44%	51%	69	57.7	0	2568
3	TORNTPHARM	1,84,303	4846	2%	3%	12%	36%	72	57.7	1.79	2138
4	APOLLOHOSP	1,24,834	8650	1%	1%	12%	10%	58	57.7	0.9	2003
5	ZYDUSLIFE	1,12,897	1132	4%	2%	26%	13%	20	57.7	0.46	5124
6	CIPLA	1,11,346	1385	2%	5%	3%	12%	22	57.7	0.02	3862
7	LAURUSLABS	99,634	1844	3%	3%	75%	114%	0	57.7	0.48	890
8	DRREDDY	96,962	1151	2%	2%	11%	8%	20	57.7	0.2	4158
9	MAXHEALTH	96,646	985	1%	10%	8%	14%	0	57.7	0.32	1442
10	LUPIN	96,620	2113	1%	11%	8%	10%	23	57.7	0.29	5355
Load More

Shareholding Pattern (%)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 66.25%	(0.01) 66.25%	(0.01) 66.25%	(0.01) 66.26%	(0.01) 66.26%	(0.01) 66.26%	(0.01) 66.26%	(0.01) 66.27%	(0.01) 66.22%	(0.01) 66.22%	(0.01) 66.22%	(0.11) 66.22%	(0.01) 66.11%	(-4.41) 66.11%	(0.01) 70.48%	(0.01) 70.48%	(0.11) 70.48%	(0.01) 70.34%	(0.01) 70.34%
FIIs	(0.31) 8.26%	(-0.61) 7.97%	(-0.31) 8.53%	(0.01) 8.86%	(-0.41) 8.86%	(0.21) 9.26%	(0.81) 9.11%	(-0.21) 8.36%	(-0.61) 8.54%	(-0.91) 9.11%	(-0.21) 9.99%	(0.21) 10.19%	(-0.11) 10.00%	(1.81) 10.07%	(-0.11) 8.23%	(-0.31) 8.30%	(-0.31) 8.64%	(0.21) 8.95%	(0.01) 8.72%
DIIs	(-0.21) 18.36%	(0.71) 18.58%	(0.41) 17.90%	(0.01) 17.50%	(0.51) 17.48%	(-0.11) 17.02%	(-0.31) 17.09%	(-0.11) 17.41%	(0.81) 17.48%	(1.11) 16.67%	(0.21) 15.60%	(-0.21) 15.36%	(0.21) 15.52%	(2.71) 15.37%	(0.21) 12.68%	(0.21) 12.46%	(0.11) 12.29%	(0.11) 12.14%	(0.01) 12.07%
Government	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.00%	0.00%	0.00%	0.46%	0.45%	0.45%	0.45%	0.45%	0.45%	0.45%	0.43%
Public	7.14%	7.20%	7.32%	7.38%	7.38%	7.45%	7.51%	7.94%	7.76%	8.00%	8.21%	7.78%	7.91%	8.00%	8.15%	8.31%	8.14%	8.12%	8.43%
No. of Shareholders	67,955	65,409	67,785	68,882	70,827	66,896	64,315	70,316	55,488	54,351	56,277	54,874	83,549	59,798	62,048	64,445	60,759	57,897	52,263

Quarterly Results

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	1422	1375	1354	1303	1170	1146	1187	1145	1054	1105	1028	1021	882	972	938	951	870	838	885	748
Sales Growth % (YoY)	21.5%	20%	14.1%	13.8%	11%	3.7%	15.4%	12.1%	19.5%	13.7%	9.6%	7.4%	1.3%	16%	6%	27.1%	15%	11.9%	23.6%	11.9%
Sales Growth % (QoQ)	3.4%	1.6%	3.9%	11.4%	2.1%	-3.5%	3.7%	8.6%	-4.6%	7.5%	0.7%	15.8%	-9.3%	3.6%	-1.4%	9.3%	3.8%	-5.3%	18.3%	-
Expenses	1088	993	1026	951	873	825	875	815	776	791	738	750	732	802	742	729	664	598	622	528
Operating Profit	333	382	328	351	297	321	311	330	278	314	291	271	149	170	196	222	207	240	263	220
OPM %	23	28	24	27	25	28	26	29	26	28	28	27	17	17	21	23	24	29	30	29
Other Income	61	25	59	26	18	30	19	26	36	14	21	32	37	35	40	33	29	24	30	33
Interest	2	5	3	5	6	8	6	1	2	2	2	1	1	3	1	1	7	1	0	2
Depreciation	45	44	43	41	40	36	34	34	34	34	34	33	33	33	33	32	31	32	32	31
Profit before tax	347	359	341	331	269	307	290	322	278	291	276	269	152	168	203	222	198	231	260	220
Tax %	23	24	24	23	16	24	25	24	27	28	29	23	20	20	23	21	24	17	25	21
Net Profit	267	274	260	255	225	233	216	246	203	210	195	208	122	135	157	175	151	192	196	174
Net Profit Growth % (QoQ)	-2.6%	5.4%	2%	13.3%	-3.4%	7.9%	-12.2%	21.2%	-3.3%	7.7%	-6.2%	70.5%	-9.6%	-14%	-10.3%	15.9%	-21.4%	-2%	12.6%	-
Net Profit Growth % (YoY)	18.7%	17.6%	20.4%	3.7%	10.8%	11%	10.8%	18.3%	66.4%	55.6%	24.2%	18.9%	-19.2%	-29.7%	-19.9%	0.6%	-	-	-	-
TTM Net Profit	1056	1014	973	929	920	898	875	854	816	735	660	622	589	618	675	714	713	562	370	0
EPS in Rs	21.35	21.91	20.83	20.44	18.03	18.64	17.33	19.68	15.82	16.39	15.24	16.24	9.54	10.5	12.22	13.63	11.8	14.78	15.1	13.39

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Sales	5453	4648	4209	3743	3341	2890	2588	2055	2126	1983	1749	1474	1208	931
Sales Growth %	17.3%	10.4%	12.4%	12%	15.6%	11.7%	25.9%	-3.3%	7.2%	13.4%	18.7%	22%	29.8%	37.4%
Expenses	4058	3379	3037	2934	2408	1889	1904	1489	1467	1292	1155	968	840	706
Operating Profit	1395	1269	1172	808	933	1001	683	567	658	691	594	505	369	224
OPM %	26	27	28	22	28	35	26	28	31	35	34	34	31	24
Other Income	172	85	85	74	112	24	88	21	24	20	14	8	14	6
Interest	16	21	7	6	10	8	12	1	0	1	5	6	9	19
Depreciation	173	144	135	131	125	116	96	72	60	61	44	52	44	34
Profit before tax	1378	1189	1114	745	909	900	664	514	623	648	559	456	330	177
Tax %	23	23	27	21	22	27	30	25	25	22	26	32	29	37
Net Profit	1056	920	816	588	713	654	468	387	469	507	416	310	234	112
Net Profit Growth %	14.8%	12.7%	38.8%	-17.5%	9%	39.7%	20.9%	-17.5%	-7.5%	21.9%	34.2%	32.5%	108.9%	-
EPS in Rs	84.52	73.68	63.7	45.89	55.63	50.38	35.73	29.56	35.5	38.4	31.49	23.47	17.75	8.49
Dividend Payout %	0	38	79	15	11	13	24	20	0	23	17	17	15	13

Cash Flows

	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Cash from Operating Activity	1157	785	792	562	576	457	375	281	609	326	279	212	234
Cash from Investing Activity	-377	65	-560	-74	-282	-224	-223	-256	-383	-209	-158	-188	-104
Cash from Financing Activity	-733	-1051	-108	-460	-318	-129	-147	0	-202	-117	-105	-20	-104
Net Cash Flow	47	-201	124	28	-24	104	4	25	24	0	16	4	26

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Equity Capital	25	25	25	25	25	25	17	17	18	18	18	18	18	18	18	12
Reserves	4502	4290	3765	3652	3542	3363	3247	2978	2581	2228	2024	1550	1173	823	576	382
Borrowings	260	246	47	33	35	36	25	31	75	36	2	1	81	72	130	125
Other Liabilities	1368	1112	1067	1081	927	1159	711	702	619	383	383	254	207	233	226	200
Total Liabilities	6155	5672	4904	4790	4530	4582	4000	3729	3293	2664	2426	1823	1479	1146	949	718
Fixed Assets	1867	1873	1762	1451	1479	1496	1512	1541	1472	1178	1053	589	451	288	279	273
CWIP	258	146	176	349	256	209	153	108	132	262	61	339	240	170	94	12
Investments	588	874	464	702	349	535	147	176	79	78	190	182	86	60	63	8
Other Assets	3441	2779	2502	2289	2446	2341	2188	1904	1610	1147	1122	713	703	629	513	425
Total Assets	6155	5672	4904	4790	4530	4582	4000	3729	3293	2664	2426	1823	1479	1146	949	718

Delivery

Delivery Data: AJANTPHARM

#	Date	3168 20% 3796	Value (Cr)	Q/T 7	Del 40	Del 58
1	4-Sep	3465	23	6	63	14
2	3-Sep	3521	15	3	40	6
3	2-Sep	3482	34	6	59	20
4	1-Sep	3505	31	5	48	15
5	31-Aug	3602	22	6	52	12
6	28-Aug	3557	14	3	52	7
7	27-Aug	3544	18	4	62	11
8	26-Aug	3552	13	6	56	7
9	25-Aug	3555	41	6	59	24
10	24-Aug	3580	24	5	53	13
11	21-Aug	3640	19	3	48	9
12	20-Aug	3659	25	4	36	9
13	19-Aug	3698	31	5	29	9
14	18-Aug	3706	54	7	50	27
15	17-Aug	3718	41	4	52	21
16	14-Aug	3673	35	5	52	18
17	13-Aug	3615	50	6	40	20
18	12-Aug	3541	29	5	55	16
19	11-Aug	3507	31	5	48	15
20	10-Aug	3506	15	6	48	7
21	7-Aug	3489	12	4	56	7
22	6-Aug	3470	17	7	53	9
23	5-Aug	3438	43	5	46	20
24	4-Aug	3525	30	5	50	15
25	3-Aug	3514	42	5	55	23
26	31-Jul	3465	72	6	37	27
27	30-Jul	3436	139	8	18	24
28	29-Jul	3396	35	6	61	21
29	28-Jul	3342	26	4	57	15
30	27-Jul	3386	28	5	52	14
31	24-Jul	3370	17	3	42	7
32	23-Jul	3440	26	4	40	10
33	22-Jul	3459	34	6	36	12
34	21-Jul	3575	73	8	35	26
35	20-Jul	3469	19	6	50	9
36	17-Jul	3419	32	6	46	15
37	16-Jul	3453	39	4	54	21
38	15-Jul	3454	17	5	44	7
39	14-Jul	3409	30	5	53	16
40	13-Jul	3421	47	4	54	25
41	10-Jul	3349	18	3	56	10
42	9-Jul	3308	19	3	48	9
43	8-Jul	3279	41	5	54	22
44	7-Jul	3314	23	4	58	13
45	6-Jul	3374	54	6	45	24
46	3-Jul	3326	28	4	50	14
47	2-Jul	3345	26	5	36	9
48	1-Jul	3348	34	5	42	14
49	30-Jun	3423	56	6	37	21
50	29-Jun	3384	310	10	35	109

Daily Market Cap

Date	Total Market Cap	Change	Chg %
04-Sep	43,400c	652c	1.48
03-Sep	44,052c	194c	0.44
01-Sep	43,858c	153c	0.35
31-Aug	44,011c	6c	0.01
27-Aug	44,004c	542c	1.22
26-Aug	44,547c	19c	0.04
25-Aug	44,528c	220c	0.49
24-Aug	44,748c	1,037c	2.27
21-Aug	45,785c	325c	0.70
19-Aug	46,110c	250c	0.54
18-Aug	46,360c	169c	0.36
17-Aug	46,529c	457c	0.99
14-Aug	46,071c	986c	2.19
13-Aug	45,085c	780c	1.76
12-Aug	44,306c	417c	0.93
11-Aug	44,723c	887c	2.02
10-Aug	43,836c	399c	0.92
06-Aug	43,437c	658c	1.54
05-Aug	42,779c	1,092c	2.49
04-Aug	43,871c	519c	1.20
31-Jul	43,353c	505c	1.18
30-Jul	42,848c	566c	1.34
29-Jul	42,282c	616c	1.48
28-Jul	41,666c	650c	1.54
27-Jul	42,316c	200c	0.47
24-Jul	42,116c	0	0

Stock Checklist

Price is above from 52 week high low average: 78%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: YES

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 333 fund scheme(s) across 36 fund house(s) as of Aug26 · Total value ₹15,447 Cr · 207 increasing / 38 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
Kotak Mahindra Mutual Fund	18	1.23%	-	2838.3
UTI Mutual Fund	36	1.71%	+0.14%	2535.2
Nippon India Mutual Fund	10	0.79%	+0.11%	2329.8
Aditya Birla Sun Life Mutual Fund	28	0.83%	+0.44%	1910.8
Canara Robeco Mutual Fund	12	1.13%	+0.17%	1217.4
HDFC Mutual Fund	16	0.87%	-0.03%	980.1
Edelweiss Mutual Fund	18	1.24%	+0.29%	805.4
SBI Mutual Fund	10	0.95%	+0.08%	621.6
WhiteOak Capital Mutual Fund	18	0.50%	+0.04%	307
PGIM India Mutual Fund	12	1.14%	+0.22%	296.7
Union Mutual Fund	22	1.34%	+0.46%	263.3
Abakkus Mutual Fund	2	2.02%	+0.24%	255.7
Baroda BNP Paribas Mutual Fund	12	1.26%	+0.13%	224.3
NJ Mutual Fund	4	1.93%	+0.10%	223.3
Mahindra Manulife Mutual Fund	4	1.34%	-	167.5
Bandhan Mutual Fund	16	0.48%	-0.12%	161.7
Tata Mutual Fund	10	0.32%	-0.08%	74.3
Franklin Templeton Mutual Fund	2	1.58%	+0.01%	72.8
Motilal Oswal Mutual Fund	8	0.24%	+0.05%	34
Bank of India Mutual Fund	2	0.90%	-0.01%	31.9
Shriram Mutual Fund	12	2.02%	+0.60%	23.4
DSP Mutual Fund	6	1.57%	-0.08%	14.6
ICICI Prudential Mutual Fund	8	0.40%	-0.03%	14.4
Trust Mutual Fund	4	0.44%	-0.14%	8.1
Navi Mutual Fund	8	0.47%	+0.08%	6.9
Samco Mutual Fund	4	0.86%	-	6.5
LIC Mutual Fund	6	0.96%	+0.58%	6
The Wealth Company Mutual Fund	2	1.31%	+0.38%	4.8
Zerodha Mutual Fund	4	0.18%	-	3.2
ITI Mutual Fund	2	1.28%	-	2.9
PGIM India Asset Management Private Limite	1	1.08%	+0.16%	2
Jio BlackRock Mutual Fund	2	0.26%	+0.05%	1.2
Angel One Mutual Fund	4	0.42%	+0.91%	0.8
Groww Mutual Fund	4	0.08%	+0.02%	0.6
Axis Mutual Fund	2	0.07%	-	0.5
Mirae Asset Mutual Fund	4	0.11%	+0.01%	0.2

Ajanta Pharma Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements